Regular readers will remember that I wrote about Zetia back in November.  That post had some important background for this week's news, and a handy lesson about the difference between clinical and intermediate outcomes in medical studies.  If you missed it, you may want to check it out.  This week, Merck released the data from a study comparing the growth of cholesterol plaques in the arteries of patients taking Zocor (a cholestero...